Trial Profile
Randomized double-blind phase II trial of docetaxel and imatinib versus docetaxel and placebo in metastatic androgen-independent prostate cancer (AIPC) with bone metastases
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Imatinib
- Indications Prostate cancer
- Focus Therapeutic Use
- 02 Oct 2005 New trial record.